GL1X · GenesisL1 explorer

Research workbench

Discovery of the highly potent PI3K/MTOR dual inhibitor pf-04691502 through structure based drug design

Analyse Discovery of the highly potent PI3K/MTOR dual inhibitor pf-04691502 through… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3ML8
Type
protein
Length
843 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform
EC
2.7.1.153
UniProt
P48736
Ligands
ML8
Pockets
15 · best druggability 0.82

Structure

x-ray diffraction · 1 distinct chain · 43% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
APhosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma isoform (EC 2.7.1.153)protein84343% helix, 15% strandP48736

Ligands and binding sites

  • ML8 · 8-cyclopentyl-6-[3-(hydroxymethyl)phenyl]-4-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

15 pockets found on a 1 Å grid, 6 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111440.820.8375empty
25390.720.8155ML8
33570.640.7929empty
42190.580.8031empty
51140.570.8423empty

Compared structures

  • 3ML8 · Discovery of the Highly Potent PI3K/mTOR Dual Inhibitor PF-04691502 through Structure… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.